Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project

BACKGROUND: Incorporating real‐world data in the drug development process allows the improvement of health outcomes by providing better representation of actual patterns of drug safety and efficacy. AIMS AND METHODS: Here, we present the results of a retroprospective, observational real‐life study o...

Descripción completa

Detalles Bibliográficos
Autores principales: Coltro, Giacomo, Sant'Antonio, Emanuela, Palumbo, Giuseppe A., Mannelli, Francesco, De Stefano, Valerio, Ruggeri, Marco, Elli, Elena M., Zanotti, Roberta, Borsani, Oscar, Bertozzi, Irene, Duminuco, Andrea, Betti, Silvia, Carli, Giuseppe, Cavalca, Fabrizio, Tanasi, Ilaria, Rumi, Elisa, Randi, Maria L., Garibaldi, Bruno, Loscocco, Giuseppe G., Guglielmelli, Paola, Vannucchi, Alessandro M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
BRIEF COMMUNICATION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134270/
https://www.ncbi.nlm.nih.gov/pubmed/36708083
http://dx.doi.org/10.1002/cam4.5618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134270/
https://www.ncbi.nlm.nih.gov/pubmed/36708083
http://dx.doi.org/10.1002/cam4.5618

Ejemplares similares